| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316795 | Clinica Chimica Acta | 2008 | 4 Pages |
Abstract
IFNβ-1a should be used for the NAb determination for an optimal evaluation of NAb-positive patients in MS patients treated with IFNβ.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Catherine Massart, Jacqueline Gibassier, Jérôme de Seze, Marc Debouverie, Thibault Moreau, Jean Pelletier, Patrick Vermersch, Gilles Edan,